Viewing Study NCT05748093


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-03-09 @ 1:59 AM
Study NCT ID: NCT05748093
Status: RECRUITING
Last Update Posted: 2024-08-09
First Post: 2023-02-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat
Sponsor: Maastricht University Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Osimertinib View
None Cobicistat View
None Pharmacokinetics View
None Boosting View
None Non-small Cell Lung Cancer View
None CNS metastases View